In August this year the American Academy of Sleep Medicine issued a new analysis of the economic burden of untreated obstructive sleep apnea (OSA) in the U.S. The result of this endeavor reveals an alarming statistic, estimating that OSA affects 29.4 million American men and women, or approximately 12% of the U.S. adult population. Furthermore, researchers calculated that the economic cost of undiagnosed OSA in 2015 is approximately $149.6 billion.
The report breaks the $149.6 billion into 4 major contributors. The highest portion is attributed to
lost productivity at $86.9 billion. Next in line is
workplace accidents at $6.5 billion,
comorbid diseases (such as diabetes, high blood presure, heart disease), and
motor vehicle accidents at $26.2 billion.